Literature DB >> 21103983

Immortal time bias does not invalidate the association of self-monitoring of blood glucose with better survival of patients with type 2 diabetes in the epidemiological study ROSSO (Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes).

B Schneider, S Martin, W A Scherbaum, L Heinemann, V Lodwig, H Kolb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21103983     DOI： 10.1007/s00125-010-1961-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

Review 1.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

2.  Immortal time bias in the study of effectiveness of interferon-beta in multiple sclerosis.

Authors:  Christel Renoux; Samy Suissa
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

3.  Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.

Authors:  S Martin; B Schneider; L Heinemann; V Lodwig; H-J Kurth; H Kolb; W A Scherbaum
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

4.  Type 2 diabetes phenotype and progression is significantly different if diagnosed before versus after 65 years of age.

Authors: 
Journal:  J Diabetes Sci Technol       Date:  2008-01

5.  Immortal time bias and survival in patients who self-monitor blood glucose in the Retrolective Study: self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (ROSSO).

Authors:  F Hoffmann; F Andersohn
Journal:  Diabetologia       Date:  2010-09-19       Impact factor: 10.122

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).

Authors:  Berthold Schneider; Stephan Martin; Lutz Heinemann; Volker Lodwig; Hubert Kolb
Journal:  Arzneimittelforschung       Date:  2007

9.  Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3).

Authors:  Hubert Kolb; Berthold Schneider; Lutz Heinemann; Volker Lodwig; Werner A Scherbaum; Stephan Martin
Journal:  J Diabetes Sci Technol       Date:  2007-07

10.  Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study.

Authors:  K F Eriksson; F Lindgärde
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.